Christopoulos, Arthur
Enlarge text Shrink text-
Save successfulThe item can be found in your Personal ZoneשגיאהLog in to your account to save
Information for Authority record
Other Identifiers
Sources of Information
- Professor of Pharmacology, NHMRC Principal Research Fellow, Theme Leader - Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences... Keywords... Drug discovery, pharmaceutical research, drug side-effects, psychiatric drugs, Supervision: Molecular pharmacology, drug discovery, receptors and signal transduction, analytical pharmacology, allosteric modulation, receptor theory ( (Monash University, Professor Arthur Christopoulos - Researcher Profile website, viewed 15 May 2015 :) )
- Prediction of functionally selective allosteric interactions at an M 3 muscarinic acetylcholine receptor mutant using Saccharomyces cerevisiae :(Stewart, G.D., Sexton, P.M., Christopoulos, A; authors of journal article, Molecular Pharmacology, 78 (2), pp. 205-214)
- Professor Arthur Christopoulos is working to end the reign of "blunt hammer" medicines. By targeting previously unappreciated drug recognition sites in the body, Arthur and his colleagues are developing medicines potent enough to offer better treatment of schizophrenia and diabetes, and selective enough to eliminate side-effects ( (The conversation website, viewed 15 May 2015 :) )
- Biomedical applications of computer modeling, 2000:CIP t.p. (Arthur Christopoulos)
Wikipedia description:
Arthur Christopoulos is an Australian pharmacologist. He is a Professor of Analytical Pharmacology at Monash University. He was a Councillor of the International Union of Basic and Clinical Pharmacology from 2018 to 2022. In 2019, he was appointed Dean of Monash University's Faculty of Pharmacy and Pharmaceutical Sciences and from 2021 to 2023, he served as the inaugural Director of Monash University's Neuromedicines Discovery Centre. He was elected a Fellow of the Australian Academy of Science in 2021.
Read more on Wikipedia >